Fortress Biotech, Inc.
FBIOFortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How FBIO's past catalysts played out
No drugs found in this phase.
Frequently asked questions
When is Fortress Biotech, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Fortress Biotech, Inc. (FBIO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track FBIO biotech catalysts?→
Add FBIO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Fortress Biotech, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.